List of works - Katrin Sproesser

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma

scientific article published in November 2017

Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS- Mutant Cancers

scientific article

Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma

scientific article published on 19 September 2013

Corrigendum: Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance.

scientific article published on 21 February 2018

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

scientific article

Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines

scientific article published in November 2017

Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma.

scientific article published on 21 March 2018

Isolation of melanoma cell subpopulations using negative selection

scientific article published on January 2014

Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence

scientific article published in December 2017

Oncogenic BRAF-Mediated Melanoma Cell Invasion

scientific article published on 18 May 2016

PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas

scientific article published on 27 September 2017

PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas

scientific article published on December 2010

Personalized Preclinical Trials in BRAF Inhibitor-Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies

scientific article published on 16 December 2015

Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance

scientific article published on 7 June 2017

Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for Melanoma

scientific article published on 13 June 2016

Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors

scientific article published on 4 April 2016

The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxel

scientific article published in January 2008

List of works by Katrin Sproesser